Skip to main content
Skip to McMaster Navigation Skip to Site Navigation Skip to main content
McMaster logo
COVID-19 information and updates

Find the most recent updates here, as well as FAQs and information for students, faculty and staff.

Promising new cholesterol medicine raises drug cost questions

The Department of Political Science's Dr. Katherine Boothe appeared on the CTV National News on March 17 to discuss the policy implications of an expensive new drug for lowering cholesterol.

Mar 21, 2017

Dr. Boothe discussed the challenges of paying for a new type of drug which promises to significant lower cholesterol in patients at high risk of heart disease, but which cost up to $7500 per patient per year. Canada does a good job of assessing whether new drugs offer value for money, but faces barriers in negotiating lower drug prices because it lacks universal pharmacare and therefore does not have a single purchaser for drugs.

To view original news segment visit CTV News.